These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1537125)

  • 1. Protective effects of adenosine in myocardial ischemia.
    Ely SW; Berne RM
    Circulation; 1992 Mar; 85(3):893-904. PubMed ID: 1537125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine, the heart, and coronary circulation.
    Hori M; Kitakaze M
    Hypertension; 1991 Nov; 18(5):565-74. PubMed ID: 1937658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?].
    Heusch G
    Z Kardiol; 1992 Nov; 81(11):596-609. PubMed ID: 1471397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microcirculatory dysfunction following perfusion with hyperkalemic, hypothermic, cardioplegic solutions and blood reperfusion. Effects of adenosine.
    Keller MW; Geddes L; Spotnitz W; Kaul S; Duling BR
    Circulation; 1991 Dec; 84(6):2485-94. PubMed ID: 1659955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.
    Babbitt DG; Virmani R; Forman MB
    Circulation; 1989 Nov; 80(5):1388-99. PubMed ID: 2805274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of the University of Wisconsin solution over simple crystalloid for extended heart preservation. A study of left ventricular pressure-volume relationship.
    Ko W; Zelano JA; Lazzaro R; Lazenby WD; Hamilton T; Isom OW; Krieger KH
    J Thorac Cardiovasc Surg; 1992 May; 103(5):980-92. PubMed ID: 1569779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic myocardial ischemia--hibernating myocardium: characteristics and limits].
    Heusch G; Schulz R
    Z Kardiol; 1993; 82 Suppl 5():133-41. PubMed ID: 8154154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy.
    Vinten-Johansen J; Zhao ZQ; Sato H
    Ann Thorac Surg; 1995 Sep; 60(3):852-7. PubMed ID: 7677546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative damage to the myocardium: a fundamental mechanism of myocardial injury.
    Loesser KE; Kukreja RC; Kazziha SY; Jesse RL; Hess ML
    Cardioscience; 1991 Dec; 2(4):199-216. PubMed ID: 1760513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology of the "hibernating" myocardium].
    Schulz R; Heusch G
    Z Kardiol; 1995; 84 Suppl 4():91-100. PubMed ID: 8585279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and therapy of myocardial reperfusion injury.
    Forman MB; Virmani R; Puett DW
    Circulation; 1990 Mar; 81(3 Suppl):IV69-78. PubMed ID: 2407376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart preservation: analysis of cardioprotective infusate characteristics. Membrane stabilization, calcium antagonism, and protease inhibition on myocardial viability: a biochemical, ultrastructural, functional study.
    Sultan I; Sunamori M; Suzuki A
    J Heart Lung Transplant; 1992; 11(4 Pt 1):607-18. PubMed ID: 1379828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
    Okada K; Yamashita C; Okada M; Okada M
    J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-spectrum cardioprotection with adenosine.
    Vinten-Johansen J; Thourani VH; Ronson RS; Jordan JE; Zhao ZQ; Nakamura M; Velez D; Guyton RA
    Ann Thorac Surg; 1999 Nov; 68(5):1942-8. PubMed ID: 10585108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium.
    Yao Z; Gross GJ
    Circulation; 1993 Jul; 88(1):235-44. PubMed ID: 8319338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat.
    Galiñanes M; Mullane KM; Bullough D; Hearse DJ
    Circulation; 1992 Aug; 86(2):598-608. PubMed ID: 1638725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
    Quintana M; Kahan T; Hjemdahl P
    Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning.
    Pagliaro P; Chiribiri A; Mancardi D; Rastaldo R; Gattullo D; Losano G
    Ital Heart J; 2003 Jun; 4(6):383-94. PubMed ID: 12898803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in functional recovery of the isolated guinea pig heart after hyperkalemic reperfusion with adenosine.
    Habazettl H; Palmisano BW; Graf BM; Roerig DL; Bosnjak ZJ; Stowe DF
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):74-84. PubMed ID: 8551791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
    Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.